LNAI
Lunai Bioworks Inc.

3,308
Mkt Cap
$17.21M
Volume
523,136.00
52W High
$14.00
52W Low
$0.63
PE Ratio
-0.09
LNAI Fundamentals
Price
$0.7344
Prev Close
$0.8179
Open
$0.746
50D MA
$0.9472
Beta
1.32
Avg. Volume
173,667.65
EPS (Annual)
-$10.78
P/B
-1.31
Rev/Employee
$0.00
$57.65
Loading...
Loading...
Lunai Bioworks, Inc. is a pre-clinical stage biotechnology company, which engages in the development of genetically modified cellular and immune-therapy technologies used for the treatment of infectious diseases and cancer. Its pipeline consists of ENOB-HV-01, ENOB- HV-11, ENOB-HV-12, ENOB-DB-01, ENOB-DC-01, ENOB-DC-11, and ENOB-DC-21. The company was founded by Rene Sindlev and Serhat Gumrukcu on January 18, 2011 and is headquartered in Los Angeles, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
29

Frequently Asked Questions

What is Market Cap of Lunai Bioworks Inc.?
What is the 52-week high for Lunai Bioworks Inc.?
What is the 52-week low for Lunai Bioworks Inc.?
What is Lunai Bioworks Inc. stock price today?
What was Lunai Bioworks Inc. stock price yesterday?
What is the PE ratio of Lunai Bioworks Inc.?
What is the Price-to-Book ratio of Lunai Bioworks Inc.?
What is the 50-day moving average of Lunai Bioworks Inc.?
How many employees does Lunai Bioworks Inc. have?

Latest LNAI News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.